DA LI POSTOJI VEZA IZMEĐU OPSTRUKTIVNE APNEJE U SNU I CEREBROVASKULARNOG INSULTA?
Sažetak
Opstruktivna apneja u snu (obstructive sleep apnea – OSA) veoma je rasprostranjena u opštoj populaciji i ima dvosmernu vezu sa cerebrovaskularnim insultom (CVI), jednim od vodećih uzroka morbiditeta i mortaliteta globalno. Nelečena teška OSA udvostručuje rizik od CVI-a. OSA može biti povezana sa povećanjem mortaliteta proisteklog iz svih uzroka i može negativno uticati na neurološki ishod kod bolesnika sa CVI-om. Patofiziološka osnova udruženosti i mogućnost prevencije i poboljšanja ishoda zahtevaju dalju evaluaciju. Terapija kontinuiranim pozitivnim pritiskom (CPAP) u disajnim putevima tokom sna povezana je sa smanjenim rizikom od CVI-a kod OSA bolesnika, ali rezultati su varijabilni. Lečenje post CVI OSA bolesnika CPAP terapijom preporučuje se u sklopu otklanjanja više faktora rizika uključenih u patogenezu CVI-a.
Reference
Bassetti CLA, Randerath W, Vignatelli L, Ferini-Strambi L, Brill AK, Bonsignore MR, et al. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Eur Respir J. 2020;55:1901104. [CrossRef] [PubMed]
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global pre-valence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019; 7(8):687-98. [CrossRef] [PubMed]
Carberry JC, Amatoury J, Eckert DJ. Personalized management approach for OSA. Chest. 2018;153(3): 744-55. [CrossRef] [PubMed]
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-54. [CrossRef] [PubMed]
Ferini-Strambi L, Fantini ML. Cerebrovascular diseases and sleep-disordered breathing. Clin Exp Hypertens. 2006;28(3-4):225-31. [CrossRef] [PubMed]
Gorelik BP. The global burden of stroke: persistent and disabling. Lancet Neurol. 2019;18(5):417-18. [CrossRef] [PubMed]
McNicholas WT, Bonsignore MR; Menagment Com-mittee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: curent evidence, basic mechanisms and reasearch priorities. Eur respir J. 2007;29(1):156-78. [CrossRef] [PubMed]
Morrell MJ, Heywood P, Moosavi SH, Guz A, Stevens J. Unilateral focal lesions in the rostrolateral medulla influence chemosensitivity and breathing measured during wakefulness, sleep, and exercise. J Neurol Neurosurg Psychiatry. 1999;67(5):637-45. [CrossRef] [PubMed]
Nogués MA, Roncoroni AJ, Benarroch E. Breathing control in neurological diseases. Clin Auton Res. 2002; 12(6):440-9. [CrossRef] [PubMed]
Park J, Ramar K, Olson E. Updates on Definition, Consequences, and Management of Obstructive Sleep Apnea. Mayo Clin Proc. 2011;86(6):549-54. [CrossRef] [PubMed]
Parra O, Arboix A, Montserrat JM, Quintó L, Bechich S, García-Eroles L. Sleep related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J. 2004;24(2):267-72. [CrossRef] [PubMed]
Roux F, D'Ambrosio C, Mohsenin V. Sleep-related Breathing Disorderes and Cardiovascular Diseae. Am J Med. 2000;108(5):396-402. [CrossRef] [PubMed]
Stevens D, Martins RT, Mukherjee S, Vakulin A. Post-Stroke Sleep-Disordered Breathing Pathophysiology and Therapy Options. Front Surg. 2018;5:9. [CrossRef] [PubMed]
WHO MONICA Project Investigators. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease). J Clin Epide-miol. 1988;41:105-14. [CrossRef] [PubMed]